Risk Factors Update Summary
- Net losses decreased from $92.2 million in 2022 to $78.3 million in 2023.
- Accumulated deficit increased from $746 million to $825 million.
- Share repurchase program authorized up to $100 million in 2023.
- Revenue grew from $541 million in 2021 to $683 million in 2022, a 26% increase.
- Issued patents increased from 26 in 2022 to 38 in 2023.
- Revenue derived from international operations increased from 42% in 2021 to 45% in 2023.
- U.S. federal net operating losses decreased from $407.4 million in 2022 to $372.5 million in 2023.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1660280&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.